Franklin Resources’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-71,138
Closed -$368K 3262
2025
Q4
$368K Sell
71,138
-1,085
-2% -$5.26K ﹤0.01% 2539
2025
Q3
$305K Buy
72,223
+48,873
+209% +$227K ﹤0.01% 2658
2025
Q2
$85.5K Sell
23,350
-49,211
-68% -$183K ﹤0.01% 2867
2025
Q1
$313K Buy
72,561
+50,256
+225% +$203K ﹤0.01% 2469
2024
Q4
$71.4K Buy
22,305
+260
+1% +$872 ﹤0.01% 2779
2024
Q3
$68.1K Buy
22,045
+202
+0.9% +$567 ﹤0.01% 2775
2024
Q2
$61.2K Buy
21,843
+676
+3% +$1.81K ﹤0.01% 2716
2024
Q1
$60.1K Buy
+21,167
New +$71.9K ﹤0.01% 2755
2023
Q2
Sell
-10,954
Closed -$23.3K 2749
2023
Q1
$23.3K Buy
+10,954
New +$27.1K ﹤0.01% 2244

Other funds holding ORGO

Franklin Resources's ORGO Position: Q1 2026 in Review

Franklin Resources sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 71,138 shares — an estimated $368K sold.

Franklin Resources first reported a position in ORGO in Q1 2023 and held it in 9 quarters. The position peaked at $368K in Q4 2025. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • Franklin Resources reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • Franklin Resources sold 71,138 Organogenesis Holdings shares in Q1 2026, an estimated $368K.
  • Franklin Resources first reported a position in Organogenesis Holdings in Q1 2023 and held it in 9 quarters.
  • Franklin Resources's Organogenesis Holdings position peaked at $368K in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on Franklin Resources's 13F filing for Q1 2026, filed 13 May 2026.